Skip to main content
SpringerLink
Log in

Analysis of CYP21A2 gene mutations in patients from Ukraine with congenital adrenal hyperplasia

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

In the article, the data on the distribution of CYP21A2 gene mutations (gene deletion/conversion, c.290-13C>A/G, E110Vfs, I172N, cluster of mutations I236N, V237E, M239K, V281L, Q318X, and R356W) among Ukrainian patients with CAH (congenital adrenal hyperplasia) of different clinical phenotypes are presented. The most common mutation in the studied group (n = 27) is the CYP21A2 gene deletion/conversion. Possible patterns of the studied mutations distribution in different populations of the world and the patients’ genotype–phenotype association are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Merke, D.P. and Bornsterin, S.R., Congenital adrenal hyperplasia, Lancet, 2000, vol. 365, pp. 2125–2136.

    Article  Google Scholar 

  2. Levine, L.S., Congenital adrenal hyperplasia, Pediatr. Rev., 2000, vol. 21, no. 5, pp. 159–170.

    Article  CAS  PubMed  Google Scholar 

  3. Baumgartner-Parzer, S.M., Nowotny, P., Heinze, G., Waldhäusl, W., and Vierhapper, H., Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population, J. Clin. Endocrinol. Metab., 2005, vol. 90, no. 2, pp. 775–778.

    Article  CAS  PubMed  Google Scholar 

  4. New, M.I., Extensive clinical experience: nonclassical 21-hydroxylase deficiency, J. Clin. Endocrinol. Metab., 2006, vol. 91, no. 11, pp. 4205–4214.

    Article  CAS  PubMed  Google Scholar 

  5. Stenson, J.A., Thomas, N.S.T., Abeysinghe, S., Krawczak, M., and Cooper, D.N., Human gene mutation database (HGMD®): 2003 update, Hum. Mutat., 2003, vol. 21, no. 6, pp. 577–581.

    Article  CAS  PubMed  Google Scholar 

  6. Haider S., Islam B., D’Atri V., Sgob M., Poojari, C., Sun, L., Yuen, T., Zaidi, M., and New, M.I., Structure-phenotype correlation of human CYP21A2 mutations in congenital adrenal hyperplasia, Proc. Natl. Cad. Sci. U. S. A., 2013, vol. 110, no. 7, pp. 2605–2610.

    Article  CAS  Google Scholar 

  7. Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, 2nd ed., New York: Cold Spring Harbor Lab. Press, 1989.

    Google Scholar 

  8. Chernushyn, S.Yu. and Livshits, L.A., Analysis CYP21A2 gene mutations technique in patients with congenital adrenal hyperplasia, Biotechnol. Acta, 2014, vol. 7, no. 1, pp. 75–79.

    Article  CAS  Google Scholar 

  9. Stikkelbroeck, N.M., Hoefsloot, L.H., de Wijs, I.J., Otten, B.J., Hermus, A.R., and Sistermans, E.A., CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: six novel mutations and a specific cluster of four mutations, J. Clin. Endocrinol. Metab., 2003, vol. 88, no. 8, pp. 3852–3859.

    Article  CAS  PubMed  Google Scholar 

  10. Baş, F., Kayserili, H., Darendeliler, F., Uyguner, O., Günöz, H., Yüksel Apak, M., Atalar, F., Bundak, R., Wilson R.C., New, M.I., Wollnik, B., and Saka, N., CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children, J. Clin. Res. Pediatr. Endocrinol., 2009, vol. 1, no. 3, pp. 116–128.

    PubMed  PubMed Central  Google Scholar 

  11. Vrzalová, Z., Hrubá, Z., St’ahlová Hrabincová, E., Pouchlá, S., Votava, F., Kolousková, S., and Fajkusová, L., Identification of CYP21A2 mutant alleles, in Czech patients with 21-hydroxylase deficiency, Int. J. Mol. Med., 2010, vol. 26, no. 4, pp. 595–603.

    PubMed  Google Scholar 

  12. Sadeghi F., Yurur-Kutluay, N., Berberoglu, M., Cetinkaya, E., Aycan, Z., Kara, C., Ilgin Ruhi, H., Ocal, G., Sklar, Z., Elhan, A., and Tukun, A., Identification of frequency and distribution of the nine most frequent mutations among patients with 21-hydroxylase deficiency in Turkey, J. Clin. Endocrinol. Metab., 2008, vol. 21, no. 8, pp. 781–787.

    CAS  Google Scholar 

  13. Krone, N., Braun A., Roscher, A.A., Knorr, D., and Schwarz, H.P., Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from Southern Germany, J. Clin. Endocrinol. Metab., 2000, vol. 85, no. 3, pp. 1059–1065.

    Article  CAS  PubMed  Google Scholar 

  14. Levo A. and Partane, J., Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for population history of defective alleles, Hum. Genet., 1997, vol. 99, no. 4, pp. 488–497.

    Article  CAS  PubMed  Google Scholar 

  15. Higashi, Y., Hiromasa T., Tanae, A., Miki, T., Nakura, J., Kondo, T., Ohura, T., Ogawa, E., Nakayama, K., and Fujii-Kuriyama, Y., Effects of individual mutations in the P350(C21) pseudogene on the P-450(C21) activity and distribution in the genomes of congenital steroid 21-hydroxylase deficiency, J. Biochem. (Tokyo), 1991, vol. 109, no. 4, pp. 638–644.

    CAS  Google Scholar 

  16. Ordonez-Sanchez, M.L., Ramirez-Jimenez, S., Lopez-Gutierrez, A.U., Riba, L., Gamboa-Cardiel, S., Cerrillo-Hinojosa, M., Altamirano-Bustamante, N., Calzada-Leon, R., Robles-Valdes, C., Mendoza-Morfin, F., and Tusie-Luna, M.T., Molecular genetic analysis of carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations, Hum. Genet., 1998, vol. 102, no. 2, pp. 170–177.

    Article  CAS  PubMed  Google Scholar 

  17. Baumgartner-Parzer, S.M., Nowotny P., Heinze, G., Waldhäusl, W., and Vierhapper, H., Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population, J. Clin. Endocrinol. Metab., 2005, vol. 90, no. 2, pp. 775–778.

    Article  CAS  PubMed  Google Scholar 

  18. Speiser, P.W. and White, P., Congenital adrenal hyperplasia New England, J. Med., 2003, vol. 349, no. 8, pp. 776–788.

    CAS  Google Scholar 

  19. Charmandari, E., Eisenhofer, G., Mehlinger, S.L., Carlson, A., Wesley, R., Keil, M.F., Chrousos, G.P., New M.I., and Merke, D.P., Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency, J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 7, pp. 3031–3037.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Institute of Molecular Biology and Genetics of NASU, Kiev, Ukraine

    S. Yu. Chernushyn & L. A. Livshits

Authors
  1. S. Yu. Chernushyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. A. Livshits
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. A. Livshits.

Additional information

Original Ukrainian Text © S.Yu. Chernushyn, L.A. Livshits, 2016, published in Tsitologiya i Genetika, 2016, Vol. 50, No. 3, pp. 42–45.

The article was translated by the authors.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chernushyn, S.Y., Livshits, L.A. Analysis of CYP21A2 gene mutations in patients from Ukraine with congenital adrenal hyperplasia. Cytol. Genet. 50, 183–186 (2016). https://doi.org/10.3103/S0095452716030026

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452716030026

Keywords

Search

Navigation